|
Number of NDAs Received by Calendar Year*
|
Calendar Year |
NDAs Received |
|
1970 |
87 |
|
1971 |
256 |
|
1972 |
272 |
|
1973 |
149 |
|
1974 |
129 |
|
1975 |
137 |
|
1976 |
127 |
|
1977 |
124 |
|
1978 |
121 |
|
1979 |
182 |
|
1980 |
162 |
|
1981 |
129 |
|
1982 |
202 |
|
1983 |
269 |
|
1984 |
217 |
|
1985 |
148 |
|
1986 |
120 |
|
1987 |
142 |
|
1988 |
126 |
|
1989 |
118 |
|
1990 |
98 |
|
1991 |
112 |
|
1992 |
100 |
|
1993 |
99 |
|
1994 |
114 |
|
1995 |
121 |
|
1996 |
120 |
|
1997 |
128 |
|
1998 |
121 |
|
1999 |
139 |
|
2000 |
115 |
|
2001 |
98 |
|
2002 |
105 |
|
2003 |
109 |
|
2004* |
115 |
|
2005* |
116 |
|
2006* |
123 |
Beginning in 1994, receipts
are counted based on user fee reporting requirements, which
includes all original receipts plus
those NDAs submitted after refusal to file or withdrawal.
The receipt figure does not include applications
that are unacceptable for filing because user fees were not
paid.
*Includes the Therapeutic
Biologic Products transferred from CBER to CDER effective
10/1/2003
updated through 12/31/2006
 Back
to Top 
Back to Reports
 PDF requires the free Adobe
Acrobat Reader
Date created: Jan. 16, 2007 |
